Q
Qibing Mei
Publications - 11
Citations - 19
Qibing Mei is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 11 publications receiving 19 citations.
Papers
More filters
Journal ArticleDOI
Tregs biomimetic nanoparticle to reprogram inflammatory and redox microenvironment in infarct tissue to treat myocardial ischemia reperfusion injury in mice
Fangyuan Li,Dao-zhou Liu,Miao Liu,Qifeng Ji,Bang-Le Zhang,Qibing Mei,Ying Cheng,Si-yuan Zhou +7 more
TL;DR: In this article , a regulatory T cells (Tregs) biomimetic nanoparticle (CsA@PPTK) was prepared by camouflaging nanoparticle with platelet membrane.
Journal ArticleDOI
Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice
Dao-zhou Liu,Qifeng Ji,Ying Cheng,Miao Liu,Bang-Le Zhang,Qibing Mei,Menglei Huan,Si-yuan Zhou +7 more
TL;DR: In this article , a cerebral infarction tissue targeted nanoparticle (CsA@HFn) was developed to treat cerebral ischemia/reperfusion injury, which is one of the main causes of death and disability in the world.
Journal ArticleDOI
Toll-like Receptors and Thrombopoiesis
Xiaoqing Tang,Qian Xu,Shuo Yang,Xinwu Huang,Long Wang,Feihong Huang,Jiesi Luo,Xiaogang Zhou,Anguo Wu,Qibing Mei,Chunling Zhao,Jianming Wu +11 more
TL;DR: In this paper , the authors present and discuss the relationship between platelets, inflammation and the TLR family and extend recent research on the influence of the Toll-like receptors (TLR2 and TLR4 pathways and the regulation of platelet production and function.
Journal ArticleDOI
Therapeutic effect and underlying mechanism of Shenkang injection against cisplatin-induced acute kidney injury in mice.
J.J. Su,Tingting He,Jing You,Jingjie Cao,Qianru Wang,Shousong Cao,Qibing Mei,Jing Zeng,Li Liu +8 more
TL;DR: Wang et al. as discussed by the authors investigated the therapeutic effect and associated underlying mechanism of Shenkang injection against CDDP-induced acute kidney injury (AKI) and established a CDDPinduced AKI mouse model to evaluate renal function by biochemical markers measurement and observe histopathological alterations by haemotoxylin and eosin (HE)-staining sections of renal.
Journal ArticleDOI
Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia
Long Wang,Sha Liu,Jiesi Luo,Qi Mo,Mei Ran,Ting Zhang,Xiaoxuan Li,Wenjun Zou,Qibing Mei,Jianping Chen,Jing Yang,Jing-zhang Zeng,Feihong Huang,Anguo Wu,Chunxiang Zhang,Jianming Wu +15 more
TL;DR: In this paper , the authors developed a drug screening model by the multi-grained cascade forest (gcForest) algorithm and found that 3,8-di-Omethylellagic acid 2-O-glucoside (DMAG) (10, 20 and 40 µM) promoted megakaryocyte differentiation in vitro.